Airway Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-09-09.
Airway Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on September 9, 2026. The filing reports $43.50M sold. Its industry group is Biotechnology. It names Marc Salzberg (Chairman and Chief Executive Officer), Alan Wolk (Chief Financial Officer, Chief Operating Officer, Treasurer and Secretary), Doug Loftus (Director) (SEC Form D, September 9, 2026).
Sell to companies like Airway Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-09 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Airway Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Airway Therapeutics, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Airway Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Airway Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Airway Therapeutics, Inc. →Get the full cited report on Airway Therapeutics, Inc.
What the filing shows about Airway Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Airway Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Airway Therapeutics, Inc. See pricing
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $43.50M, on the same scale — one filing against the whole group's total, so it sits low by construction.
By form type: D ×2.
What the filing shows about Airway Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Airway Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Airway Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The 2 most recent of 2 filings on CIK 0001733867, filed as Airway Therapeutics, Inc.. Read from the SEC's own submissions feed for this issuer, not from a third party. Incorporated in DE. Full history on sec.gov.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200, after redirecting from https://airwaytherapeutics.com. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Marc Salzberg is named as Chairman and Chief Executive Officer on the Form D that Airway Therapeutics, Inc. filed with the SEC on 9 September 2026, one of 5 people that filing names.
On the filing as: Executive Officer, Director.
Alan Wolk is named as Chief Financial Officer, Chief Operating Officer, Treasurer and Secretary on the Form D that Airway Therapeutics, Inc. filed with the SEC on 9 September 2026, one of 5 people that filing names.
Doug Loftus is named as Director on the Form D that Airway Therapeutics, Inc. filed with the SEC on 9 September 2026, one of 5 people that filing names.
Elise Panayotopoulous is named as Director on the Form D that Airway Therapeutics, Inc. filed with the SEC on 9 September 2026, one of 5 people that filing names.
Joe Todicsco is named as Director on the Form D that Airway Therapeutics, Inc. filed with the SEC on 9 September 2026, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2026-09-09 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Airway Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Airway Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-25 (airwaytherapeutics.com).
Each opens in a new tab, filled in for Airway Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-09-07 · Biotech raises in Atlanta
https://mentionfox.com/funding/airway-therapeutics-inc-form-d-000054